SAM
AMGN icon

Sunnymeath Asset Management’s Amgen AMGN Stock Holding History

Sunnymeath Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,200
Closed -$357K – 139
2015
Q4 		$357K Buy
+2,200
New +$346K 0.57% 59

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Sunnymeath Asset Management's AMGN Position: Q1 2016 in Review

Sunnymeath Asset Management sold out of Amgen (AMGN) in Q1 2016, closing a stake of 2,200 shares — an estimated $357K sold.

Sunnymeath Asset Management first reported a position in AMGN in Q4 2015 and held it in 1 quarter. The position peaked at $357K in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Sunnymeath Asset Management reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Sunnymeath Asset Management sold 2,200 Amgen shares in Q1 2016, an estimated $357K.
  • Sunnymeath Asset Management first reported a position in Amgen in Q4 2015 and held it in 1 quarter.
  • Sunnymeath Asset Management's Amgen position peaked at $357K in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Sunnymeath Asset Management's 13F filing for Q1 2016, filed 8 Apr 2016.